Refractory Lung Non-Small Cell Carcinoma
Also known as: Refractory Non-small cell lung cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08881 | Vemurafenib | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11595 | Atezolizumab | 1 | Active Not Recruiting | 1 |
| DB11595 | Atezolizumab | 1 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB09143 | Sonidegib | 1 | Recruiting | 1 |
| DB11930 | Varlilumab | 1 | Active Not Recruiting | 1 |
| DB09559 | Necitumumab | 1 / 2 | Recruiting | 1 |
| DB09330 | Osimertinib | 1 / 2 | Recruiting | 1 |
| DB00072 | Trastuzumab | 1 / 2 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
| DB09331 | Daratumumab | 2 | Recruiting | 1 |
| DB06205 | Hyaluronidase (human recombinant) | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |